| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119737 | Journal of Clinical Virology | 2016 | 6 Pages |
Abstract
Commercial kits were at least as sensitive as in-house tests and potentially easier to use in the field than the latter. This qualitative comparison of real-time reverse transcription PCR assays may serve as a basis for the design of future Ebola virus disease diagnostics.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Pascal Cherpillod, Manuel Schibler, Gaël Vieille, Samuel Cordey, Aline Mamin, Pauline Vetter, Laurent Kaiser,